A Multi-Center, Open-Label Phase I Study to Investigate the Effect of Different Degrees of Renal Impairment on the Single-Dose Pharmacokinetics of EVP-6124 in Patients With Renal Impairment Compared to Subjects With Normal Renal Function
Phase of Trial: Phase I
Latest Information Update: 13 Nov 2014
Price : $35 *
At a glance
- Drugs Encenicline (Primary)
- Indications Alzheimer's disease; Cognition disorders
- Focus Pharmacokinetics
- Sponsors FORUM Pharmaceuticals
- 27 Feb 2014 Status changed from active, no longer recruiting to completed, as per ClinicalTrials.gov record.
- 23 Jan 2014 As per the ClinicalTrials.gov record, status changed from recruiting to active, no longer recruiting.
- 22 Nov 2013 New trial record